Oxford Biodynamics plc (OBD) RNS Announcements

Date	Time	Date	TitleTitle (filtered)	Source
28/02/20	14:08:42	28 Feb 2020	PDMR Dealing	PDMR Dealing	RNS
26/02/20	11:49:51	26 Feb 2020	PDMR Dealing	PDMR Dealing	RNS
20/02/20	07:00:08	20 Feb 2020	OBD to present at BioTech Pharma Summit	OBD to present at BioTech Pharma Summit	RNS
13/02/20	16:41:21	13 Feb 2020	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
13/02/20	16:35:59	13 Feb 2020	Price Monitoring Extension	Price Monitoring Extension	RNS
23/01/20	07:00:10	23 Jan 2020	Publication of Annual Report and Notice of AGM	Publication of Annual Report and Notice of AGM	RNS
15/01/20	14:15:01	15 Jan 2020	EpiSwitch used in diagnosis of canine lymphoma	EpiSwitch used in diagnosis of canine lymphoma	RNS
20/12/19	07:00:03	20 Dec 2019	OBD enters into master service agreement	OBD enters into master service agreement	RNS
11/12/19	11:00:24	11 Dec 2019	PDMR Shareholding	PDMR Shareholding	RNS
10/12/19	07:00:10	10 Dec 2019	Prelim Results for year ended 30 September 2019	Prelim Results for year ended 30 September 2019	RNS
19/11/19	07:00:14	19 Nov 2019	Notice of Results	Notice of Results	RNS
08/11/19	07:02:08	8 Nov 2019	OBD's EpiSwitch featured in presentations	OBD's EpiSwitch featured in presentations	RNS
30/10/19	07:00:05	30 Oct 2019	OBD appoints Iain McInnes to Advisory Board	OBD appoints Iain McInnes to Advisory Board	RNS
25/10/19	08:00:05	25 Oct 2019	First patient enrolled in ALS biomarker study	First patient enrolled in ALS biomarker study	RNS
12/09/19	13:43:30	12 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
10/09/19	11:26:15	10 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
09/09/19	13:48:02	9 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
06/09/19	11:59:56	6 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
03/09/19	10:47:35	3 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
02/09/19	12:18:28	2 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
29/08/19	16:30:35	29 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
28/08/19	11:11:51	28 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
15/08/19	11:59:59	15 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
14/08/19	14:15:37	14 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
05/08/19	12:19:20	5 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
01/08/19	10:51:18	1 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
26/07/19	12:57:00	26 Jul 2019	PDMR Shareholding	PDMR Shareholding	RNS
19/07/19	08:00:03	19 Jul 2019	OBD to present at MAC10	OBD to present at MAC10	RNS
09/07/19	08:00:10	9 Jul 2019	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
13/06/19	08:00:16	13 Jun 2019	OBD appoints Dr Bartu Ahiska	OBD appoints Dr Bartu Ahiska	RNS
12/06/19	08:00:06	12 Jun 2019	PDMR Dealing / Grant of Share Options	PDMR Dealing / Grant of Share Options	RNS
31/05/19	08:00:05	31 May 2019	Board Transition	Board Transition	RNS
28/05/19	08:00:10	28 May 2019	Interim Results for 6 months ended 31 March 2019	Interim Results for 6 months ended 31 March 2019	RNS
03/05/19	15:00:03	3 May 2019	OBD joins ALS Biomarker study sponsored by MTPA	OBD joins ALS Biomarker study sponsored by MTPA	RNS
29/04/19	08:50:55	29 Apr 2019	Notice of Interim Results	Notice of Interim Results	RNS
23/04/19	08:00:08	23 Apr 2019	Queen's Award for Enterprise	Queen's Award for Enterprise	RNS
05/04/19	10:30:03	5 Apr 2019	Board Appointments	Board Appointments	RNS
02/04/19	08:00:22	2 Apr 2019	OBD US subsidiary and commercial lead	OBD US subsidiary and commercial lead	RNS
19/03/19	07:00:27	19 Mar 2019	OBD joins Imperial in a prostate cancer trial	OBD joins Imperial in a prostate cancer trial	RNS
14/03/19	14:13:50	14 Mar 2019	Results of Annual General Meeting	Results of Annual General Meeting	RNS
15/02/19	10:01:52	15 Feb 2019	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
25/01/19	07:00:04	25 Jan 2019	Publication of Annual Report and Notice of AGM	Publication of Annual Report and Notice of AGM	RNS
11/01/19	07:00:04	11 Jan 2019	Board Transition	Board Transition	RNS
11/12/18	07:00:15	11 Dec 2018	Final Results	Final Results	RNS
03/12/18	10:10:50	3 Dec 2018	Total Voting Rights	Total Voting Rights	RNS
23/11/18	07:00:03	23 Nov 2018	Notice of results for year ended 30 Sept 2018	Notice of results for year ended 30 Sept 2018	RNS
12/11/18	07:00:06	12 Nov 2018	Collaboration into identifying diagnosis of Autism	Collaboration into identifying diagnosis of Autism	RNS
08/11/18	07:00:18	8 Nov 2018	OBD signs fifth collaboration agreement	OBD signs fifth collaboration agreement	RNS
07/11/18	07:00:05	7 Nov 2018	Study published in Faculty of 1000 Research	Study published in Faculty of 1000 Research	RNS
06/11/18	07:00:06	6 Nov 2018	Issue of Equity	Issue of Equity	RNS

Showing 301–350 of 416 announcements

Date	Time	Date	TitleTitle (filtered)	Source
28/02/20	14:08:42	28 Feb 2020	PDMR Dealing	PDMR Dealing	RNS
26/02/20	11:49:51	26 Feb 2020	PDMR Dealing	PDMR Dealing	RNS
20/02/20	07:00:08	20 Feb 2020	OBD to present at BioTech Pharma Summit	OBD to present at BioTech Pharma Summit	RNS
13/02/20	16:41:21	13 Feb 2020	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
13/02/20	16:35:59	13 Feb 2020	Price Monitoring Extension	Price Monitoring Extension	RNS
23/01/20	07:00:10	23 Jan 2020	Publication of Annual Report and Notice of AGM	Publication of Annual Report and Notice of AGM	RNS
15/01/20	14:15:01	15 Jan 2020	EpiSwitch used in diagnosis of canine lymphoma	EpiSwitch used in diagnosis of canine lymphoma	RNS
20/12/19	07:00:03	20 Dec 2019	OBD enters into master service agreement	OBD enters into master service agreement	RNS
11/12/19	11:00:24	11 Dec 2019	PDMR Shareholding	PDMR Shareholding	RNS
10/12/19	07:00:10	10 Dec 2019	Prelim Results for year ended 30 September 2019	Prelim Results for year ended 30 September 2019	RNS
19/11/19	07:00:14	19 Nov 2019	Notice of Results	Notice of Results	RNS
08/11/19	07:02:08	8 Nov 2019	OBD's EpiSwitch featured in presentations	OBD's EpiSwitch featured in presentations	RNS
30/10/19	07:00:05	30 Oct 2019	OBD appoints Iain McInnes to Advisory Board	OBD appoints Iain McInnes to Advisory Board	RNS
25/10/19	08:00:05	25 Oct 2019	First patient enrolled in ALS biomarker study	First patient enrolled in ALS biomarker study	RNS
12/09/19	13:43:30	12 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
10/09/19	11:26:15	10 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
09/09/19	13:48:02	9 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
06/09/19	11:59:56	6 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
03/09/19	10:47:35	3 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
02/09/19	12:18:28	2 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
29/08/19	16:30:35	29 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
28/08/19	11:11:51	28 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
15/08/19	11:59:59	15 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
14/08/19	14:15:37	14 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
05/08/19	12:19:20	5 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
01/08/19	10:51:18	1 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
26/07/19	12:57:00	26 Jul 2019	PDMR Shareholding	PDMR Shareholding	RNS
19/07/19	08:00:03	19 Jul 2019	OBD to present at MAC10	OBD to present at MAC10	RNS
09/07/19	08:00:10	9 Jul 2019	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
13/06/19	08:00:16	13 Jun 2019	OBD appoints Dr Bartu Ahiska	OBD appoints Dr Bartu Ahiska	RNS
12/06/19	08:00:06	12 Jun 2019	PDMR Dealing / Grant of Share Options	PDMR Dealing / Grant of Share Options	RNS
31/05/19	08:00:05	31 May 2019	Board Transition	Board Transition	RNS
28/05/19	08:00:10	28 May 2019	Interim Results for 6 months ended 31 March 2019	Interim Results for 6 months ended 31 March 2019	RNS
03/05/19	15:00:03	3 May 2019	OBD joins ALS Biomarker study sponsored by MTPA	OBD joins ALS Biomarker study sponsored by MTPA	RNS
29/04/19	08:50:55	29 Apr 2019	Notice of Interim Results	Notice of Interim Results	RNS
23/04/19	08:00:08	23 Apr 2019	Queen's Award for Enterprise	Queen's Award for Enterprise	RNS
05/04/19	10:30:03	5 Apr 2019	Board Appointments	Board Appointments	RNS
02/04/19	08:00:22	2 Apr 2019	OBD US subsidiary and commercial lead	OBD US subsidiary and commercial lead	RNS
19/03/19	07:00:27	19 Mar 2019	OBD joins Imperial in a prostate cancer trial	OBD joins Imperial in a prostate cancer trial	RNS
14/03/19	14:13:50	14 Mar 2019	Results of Annual General Meeting	Results of Annual General Meeting	RNS
15/02/19	10:01:52	15 Feb 2019	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
25/01/19	07:00:04	25 Jan 2019	Publication of Annual Report and Notice of AGM	Publication of Annual Report and Notice of AGM	RNS
11/01/19	07:00:04	11 Jan 2019	Board Transition	Board Transition	RNS
11/12/18	07:00:15	11 Dec 2018	Final Results	Final Results	RNS
03/12/18	10:10:50	3 Dec 2018	Total Voting Rights	Total Voting Rights	RNS
23/11/18	07:00:03	23 Nov 2018	Notice of results for year ended 30 Sept 2018	Notice of results for year ended 30 Sept 2018	RNS
12/11/18	07:00:06	12 Nov 2018	Collaboration into identifying diagnosis of Autism	Collaboration into identifying diagnosis of Autism	RNS
08/11/18	07:00:18	8 Nov 2018	OBD signs fifth collaboration agreement	OBD signs fifth collaboration agreement	RNS
07/11/18	07:00:05	7 Nov 2018	Study published in Faculty of 1000 Research	Study published in Faculty of 1000 Research	RNS
06/11/18	07:00:06	6 Nov 2018	Issue of Equity	Issue of Equity	RNS

Showing 301–350 of 416 announcements

Date	Time	Date	TitleTitle (filtered)	Source
28/02/20	14:08:42	28 Feb 2020	PDMR Dealing	PDMR Dealing	RNS
26/02/20	11:49:51	26 Feb 2020	PDMR Dealing	PDMR Dealing	RNS
20/02/20	07:00:08	20 Feb 2020	OBD to present at BioTech Pharma Summit	OBD to present at BioTech Pharma Summit	RNS
13/02/20	16:41:21	13 Feb 2020	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
13/02/20	16:35:59	13 Feb 2020	Price Monitoring Extension	Price Monitoring Extension	RNS
23/01/20	07:00:10	23 Jan 2020	Publication of Annual Report and Notice of AGM	Publication of Annual Report and Notice of AGM	RNS
15/01/20	14:15:01	15 Jan 2020	EpiSwitch used in diagnosis of canine lymphoma	EpiSwitch used in diagnosis of canine lymphoma	RNS
20/12/19	07:00:03	20 Dec 2019	OBD enters into master service agreement	OBD enters into master service agreement	RNS
11/12/19	11:00:24	11 Dec 2019	PDMR Shareholding	PDMR Shareholding	RNS
10/12/19	07:00:10	10 Dec 2019	Prelim Results for year ended 30 September 2019	Prelim Results for year ended 30 September 2019	RNS
19/11/19	07:00:14	19 Nov 2019	Notice of Results	Notice of Results	RNS
08/11/19	07:02:08	8 Nov 2019	OBD's EpiSwitch featured in presentations	OBD's EpiSwitch featured in presentations	RNS
30/10/19	07:00:05	30 Oct 2019	OBD appoints Iain McInnes to Advisory Board	OBD appoints Iain McInnes to Advisory Board	RNS
25/10/19	08:00:05	25 Oct 2019	First patient enrolled in ALS biomarker study	First patient enrolled in ALS biomarker study	RNS
12/09/19	13:43:30	12 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
10/09/19	11:26:15	10 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
09/09/19	13:48:02	9 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
06/09/19	11:59:56	6 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
03/09/19	10:47:35	3 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
02/09/19	12:18:28	2 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
29/08/19	16:30:35	29 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
28/08/19	11:11:51	28 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
15/08/19	11:59:59	15 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
14/08/19	14:15:37	14 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
05/08/19	12:19:20	5 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
01/08/19	10:51:18	1 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
26/07/19	12:57:00	26 Jul 2019	PDMR Shareholding	PDMR Shareholding	RNS
19/07/19	08:00:03	19 Jul 2019	OBD to present at MAC10	OBD to present at MAC10	RNS
09/07/19	08:00:10	9 Jul 2019	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
13/06/19	08:00:16	13 Jun 2019	OBD appoints Dr Bartu Ahiska	OBD appoints Dr Bartu Ahiska	RNS
12/06/19	08:00:06	12 Jun 2019	PDMR Dealing / Grant of Share Options	PDMR Dealing / Grant of Share Options	RNS
31/05/19	08:00:05	31 May 2019	Board Transition	Board Transition	RNS
28/05/19	08:00:10	28 May 2019	Interim Results for 6 months ended 31 March 2019	Interim Results for 6 months ended 31 March 2019	RNS
03/05/19	15:00:03	3 May 2019	OBD joins ALS Biomarker study sponsored by MTPA	OBD joins ALS Biomarker study sponsored by MTPA	RNS
29/04/19	08:50:55	29 Apr 2019	Notice of Interim Results	Notice of Interim Results	RNS
23/04/19	08:00:08	23 Apr 2019	Queen's Award for Enterprise	Queen's Award for Enterprise	RNS
05/04/19	10:30:03	5 Apr 2019	Board Appointments	Board Appointments	RNS
02/04/19	08:00:22	2 Apr 2019	OBD US subsidiary and commercial lead	OBD US subsidiary and commercial lead	RNS
19/03/19	07:00:27	19 Mar 2019	OBD joins Imperial in a prostate cancer trial	OBD joins Imperial in a prostate cancer trial	RNS
14/03/19	14:13:50	14 Mar 2019	Results of Annual General Meeting	Results of Annual General Meeting	RNS
15/02/19	10:01:52	15 Feb 2019	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
25/01/19	07:00:04	25 Jan 2019	Publication of Annual Report and Notice of AGM	Publication of Annual Report and Notice of AGM	RNS
11/01/19	07:00:04	11 Jan 2019	Board Transition	Board Transition	RNS
11/12/18	07:00:15	11 Dec 2018	Final Results	Final Results	RNS
03/12/18	10:10:50	3 Dec 2018	Total Voting Rights	Total Voting Rights	RNS
23/11/18	07:00:03	23 Nov 2018	Notice of results for year ended 30 Sept 2018	Notice of results for year ended 30 Sept 2018	RNS
12/11/18	07:00:06	12 Nov 2018	Collaboration into identifying diagnosis of Autism	Collaboration into identifying diagnosis of Autism	RNS
08/11/18	07:00:18	8 Nov 2018	OBD signs fifth collaboration agreement	OBD signs fifth collaboration agreement	RNS
07/11/18	07:00:05	7 Nov 2018	Study published in Faculty of 1000 Research	Study published in Faculty of 1000 Research	RNS
06/11/18	07:00:06	6 Nov 2018	Issue of Equity	Issue of Equity	RNS

Showing 301–350 of 416 announcements

Date	Time	Date	TitleTitle (filtered)	Source
28/02/20	14:08:42	28 Feb 2020	PDMR Dealing	PDMR Dealing	RNS
26/02/20	11:49:51	26 Feb 2020	PDMR Dealing	PDMR Dealing	RNS
20/02/20	07:00:08	20 Feb 2020	OBD to present at BioTech Pharma Summit	OBD to present at BioTech Pharma Summit	RNS
13/02/20	16:41:21	13 Feb 2020	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
13/02/20	16:35:59	13 Feb 2020	Price Monitoring Extension	Price Monitoring Extension	RNS
23/01/20	07:00:10	23 Jan 2020	Publication of Annual Report and Notice of AGM	Publication of Annual Report and Notice of AGM	RNS
15/01/20	14:15:01	15 Jan 2020	EpiSwitch used in diagnosis of canine lymphoma	EpiSwitch used in diagnosis of canine lymphoma	RNS
20/12/19	07:00:03	20 Dec 2019	OBD enters into master service agreement	OBD enters into master service agreement	RNS
11/12/19	11:00:24	11 Dec 2019	PDMR Shareholding	PDMR Shareholding	RNS
10/12/19	07:00:10	10 Dec 2019	Prelim Results for year ended 30 September 2019	Prelim Results for year ended 30 September 2019	RNS
19/11/19	07:00:14	19 Nov 2019	Notice of Results	Notice of Results	RNS
08/11/19	07:02:08	8 Nov 2019	OBD's EpiSwitch featured in presentations	OBD's EpiSwitch featured in presentations	RNS
30/10/19	07:00:05	30 Oct 2019	OBD appoints Iain McInnes to Advisory Board	OBD appoints Iain McInnes to Advisory Board	RNS
25/10/19	08:00:05	25 Oct 2019	First patient enrolled in ALS biomarker study	First patient enrolled in ALS biomarker study	RNS
12/09/19	13:43:30	12 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
10/09/19	11:26:15	10 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
09/09/19	13:48:02	9 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
06/09/19	11:59:56	6 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
03/09/19	10:47:35	3 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
02/09/19	12:18:28	2 Sept 2019	PDMR Dealing	PDMR Dealing	RNS
29/08/19	16:30:35	29 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
28/08/19	11:11:51	28 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
15/08/19	11:59:59	15 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
14/08/19	14:15:37	14 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
05/08/19	12:19:20	5 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
01/08/19	10:51:18	1 Aug 2019	PDMR Dealing	PDMR Dealing	RNS
26/07/19	12:57:00	26 Jul 2019	PDMR Shareholding	PDMR Shareholding	RNS
19/07/19	08:00:03	19 Jul 2019	OBD to present at MAC10	OBD to present at MAC10	RNS
09/07/19	08:00:10	9 Jul 2019	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
13/06/19	08:00:16	13 Jun 2019	OBD appoints Dr Bartu Ahiska	OBD appoints Dr Bartu Ahiska	RNS
12/06/19	08:00:06	12 Jun 2019	PDMR Dealing / Grant of Share Options	PDMR Dealing / Grant of Share Options	RNS
31/05/19	08:00:05	31 May 2019	Board Transition	Board Transition	RNS
28/05/19	08:00:10	28 May 2019	Interim Results for 6 months ended 31 March 2019	Interim Results for 6 months ended 31 March 2019	RNS
03/05/19	15:00:03	3 May 2019	OBD joins ALS Biomarker study sponsored by MTPA	OBD joins ALS Biomarker study sponsored by MTPA	RNS
29/04/19	08:50:55	29 Apr 2019	Notice of Interim Results	Notice of Interim Results	RNS
23/04/19	08:00:08	23 Apr 2019	Queen's Award for Enterprise	Queen's Award for Enterprise	RNS
05/04/19	10:30:03	5 Apr 2019	Board Appointments	Board Appointments	RNS
02/04/19	08:00:22	2 Apr 2019	OBD US subsidiary and commercial lead	OBD US subsidiary and commercial lead	RNS
19/03/19	07:00:27	19 Mar 2019	OBD joins Imperial in a prostate cancer trial	OBD joins Imperial in a prostate cancer trial	RNS
14/03/19	14:13:50	14 Mar 2019	Results of Annual General Meeting	Results of Annual General Meeting	RNS
15/02/19	10:01:52	15 Feb 2019	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
25/01/19	07:00:04	25 Jan 2019	Publication of Annual Report and Notice of AGM	Publication of Annual Report and Notice of AGM	RNS
11/01/19	07:00:04	11 Jan 2019	Board Transition	Board Transition	RNS
11/12/18	07:00:15	11 Dec 2018	Final Results	Final Results	RNS
03/12/18	10:10:50	3 Dec 2018	Total Voting Rights	Total Voting Rights	RNS
23/11/18	07:00:03	23 Nov 2018	Notice of results for year ended 30 Sept 2018	Notice of results for year ended 30 Sept 2018	RNS
12/11/18	07:00:06	12 Nov 2018	Collaboration into identifying diagnosis of Autism	Collaboration into identifying diagnosis of Autism	RNS
08/11/18	07:00:18	8 Nov 2018	OBD signs fifth collaboration agreement	OBD signs fifth collaboration agreement	RNS
07/11/18	07:00:05	7 Nov 2018	Study published in Faculty of 1000 Research	Study published in Faculty of 1000 Research	RNS
06/11/18	07:00:06	6 Nov 2018	Issue of Equity	Issue of Equity	RNS

Showing 301–350 of 416 announcements

Oxford Biodynamics plc RNS

Oxford Biodynamics plc RNS